Emergence of VanB phenotype-vanA genotype Enterococcus faecium clinical isolate in Bulgaria  by Strateva, Tanya et al.
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etter to the Editormergence  of  VanB  phenotype-vanA  genotype
olanterococcus faecium  clinical  is
ear Editor,
anA glycopeptide resistance is characterized by acquired
nducible resistance to both vancomycin and teicoplanin,
hereas the VanB phenotype is characterized by variable
evels  of resistance to vancomycin but susceptibility to
eicoplanin.1 Here we report a vancomycin-resistant Entero-
occus  faecium (VREFm) strain with VanB phenotype-vanA
enotype incongruence.
In  the course of antimicrobial susceptibility testing of
ll  Enterococcus spp. isolates, we identiﬁed a VREFm strain
BG139/2013) exhibiting high-level resistance to vancomycin
MIC  > 256 g/mL) and susceptibility to teicoplanin (4 g/mL)
ccording to the Clinical and Laboratory Standards Institute
013  recommendations, hence having the VanB phenotype.
G139/2013 strain was  isolated on 22 February 2013 from the
lood  of a male patient aged 37 years at a Department of
ephrology and Dialysis in Gabrovo, Bulgaria. Species iden-
iﬁcation  was  done by the VITEK 2 system (bioMérieux) and
onﬁrmed  using multiplex polymerase chain reaction (PCR)
s  previously described.2
Antimicrobial susceptibility testing was  performed
y the Etest (LIOFILCHEM). BG139/2013 showed high-
evel  gentamicin resistance; resistance toward ampicillin
MIC  > 256 g/mL), erythromycin (>256), tetracycline (24),
iproﬂoxacin (>32); and susceptibility to linezolid (1.5) and
hloramphenicol (1.5).
Bacterial DNA was  extracted using the ISOLATE Genomic
NA  Mini Kit (Bioline, UK) according to the manu-
acturer’s instructions. The glycopeptide antibiotic resis-
ance  genes were ampliﬁed with speciﬁc primers as
escribed before: A1/A2, B1/B23 and vanD-F/vanD-R.4 The
rimers  for the vanA and vanD genes were actualized:
anAD-F 5′-GARGAYGGMWSCATMCARGGY-3′ and vanAD-R
′-MGTRAAWCCNGGCAKRGTRTT-3′. Each 25-L PCR mixture
onsisted  of 3 L of template DNA; a 0.1 M of each primer;
2.5  L of MyTaq  PCR mix  (Bioline) and 7.5 L of ultrapure
8.2 M PCR water (Bioline). DNA ampliﬁcation was  performed
sing  the following protocol: initial denaturation (95 ◦C for
 min), followed by 35 cycles of denaturation (95 ◦C for 45 s),te  in  Bulgaria
annealing  (51.3–60 ◦C for 45 s) and extension (72 ◦C for 60 s),
with  a single ﬁnal extension of 7 min  at 72 ◦C. For primer modi-
ﬁcation  and phylogenetic analyses we  used the GenBank NCBI
(National  Center for Biotechnology Information) sequence
database: FJ545640, JN207933, JN207928, JN207930, EF206284,
X56895  (VanA strains); AY665551, U35369, AF310956 and
AY145441  (VanB); AF175293, AF153050, AF130997, AY489045,
AY082011 and AF277571 (VanD). The sequence reactions
and  phylogenetic analyses were performed as previously
described.5
A 630 bp PCR product was yielded only with the vanAD-
F/vanAD-R primer pair at an annealing temperature of 51.3 ◦C.
After sequencing, the data for the phylogenetic analysis
consisted of a 450 nucleotides fragment, or 150 amino acid
(aa)  residues, including 125–274 aa of vanA. The predicted aa
sequence  of the BG139/2013 isolate was  100% identical to the
known  vanA sequences (GenBank accession no AAW56079.1
and  AGU36307.1). The alignment with JN207933, JN207928 and
JN207930  showed that our isolate had a non-synonymous
nucleotide mutation leading to the substitution of alanine
with  valine in position 227 in the amino acid chain. The phy-
logenetic  tree showed that BG139/2013 isolate groups together
with  cluster vanA gene isolates of E. faecium (Fig. 1).
The  VanA phenotype resistance is determined by genes
located  on transposon Tn1546, which includes the vanRS reg-
ulatory  system that activates the transcription of resistance
genes  (vanHAXYZ).6 The studied gene fragment makes up a
part  of the protein active site and was  identiﬁed as vanA
genotype in the phylogenetic analysis. On the other hand,
BG139/2013 had VanB phenotype. A relation has been reported
between  an impairment of the response to teicoplanin (i.e.
low-level  teicoplanin resistance) and amino acid substitutions
due  to three point mutations in the N-terminal region of vanS.6
Thus, the substitution found in position 227 seems to be unre-
lated  to the discrepancy between the phenotype and genotype.
This  discrepancy could most probably be attributed to non-
synonymous mutations in the N-terminal region of vanS.In  conclusion, further studies on the genes responsible for
the  phenotype resistance of the BG139/2013 isolate, and on
vanS  in particular, are needed. To our knowledge, the studied
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Fig. 1 – Phylogenetic tree based on alignment of a 150 amino acid predicted sequence from isolate BG139/2013 with E.
faecium reference strains. The tree was  constructed from aligned amino acid positions in the ﬁnal data set using MUSCLE.
One thousand bootstrap replications were  used to build the phylogenetic tree.
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6VanB phenotype-vanA genotype E. faecium strain is the ﬁrst of
its  kind to be isolated in Bulgaria.
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